Steel Peak Wealth Management LLC Crispr Therapeutics Ag Transaction History
Steel Peak Wealth Management LLC
- $2.25 Billion
- Q3 2024
A detailed history of Steel Peak Wealth Management LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Steel Peak Wealth Management LLC holds 10,183 shares of CRSP stock, worth $528,294. This represents 0.02% of its overall portfolio holdings.
Number of Shares
10,183
Previous 15,660
34.97%
Holding current value
$528,294
Previous $845,000
43.43%
% of portfolio
0.02%
Previous 0.04%
Shares
15 transactions
Others Institutions Holding CRSP
# of Institutions
499Shares Held
56.8MCall Options Held
1.7MPut Options Held
1.8M-
Capital International Investors Los Angeles, CA7.87MShares$408 Million0.09% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.5MShares$389 Million3.35% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.97MShares$154 Million0.1% of portfolio
-
Nikko Asset Management Americas, Inc.2.97MShares$154 Million1.61% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$144 Million0.0% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $4.05B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....